Proinsulin as a Marker for the Development of NIDDM in Japanese-American Men

Disproportionate hyperproinsulinemia is one manifestation of the B-cell dysfunction observed in non-insulin-dependent diabetes mellitus (NIDDM), but it is unclear when this abnormality develops and whether it predicts the development of NIDDM. At baseline, measurements of proinsulin (PI) and immunoreactive insulin (IRI) levels were made in 87 second-generation Japanese-American men, a population at high risk for the subsequent development of NIDDM, and, by using World Health Organization criteria, subjects were categorized as having normal glucose tolerance (NGT; n = 49) or impaired glucose tolerance (IGT; n = 38). After a 5-year follow-up period, they were recategorized as NGT, IGT, or NIDDM using the same criteria. After 5 years, 16 subjects had developed NTODM, while 71 had NGT or IGT. Individuals who developed NIDDM were more obese at baseline, measured as intra-abdominal fat (IAF) area on computed tomography (P = 0.046) but did not differ in age from those who continued to have NGT or IGT. At baseline, subjects who subsequently developed NIDDM had higher fasting glucose (P = 0.0042), 2-h glucose (P = 0.0002), fasting C-peptide (P = 0.0011), and fasting PI levels (P = 0.0033) and disproportionate hyperproinsulinemia (P = 0.056) than those who continued to have NGT or IGT after 5 years of follow-up. NIDDM incidence was positively correlated with the absolute fasting PI level (relative odds = 2.35; P = 0.0025), even after adjustment for fasting IRI, IAF, and body mass index (relative odds = 2.17; P = 0.013). Because 12 of the 16 subjects who developed NTODM had IGT at baseline, the 38 IGT subjects were also examined separately. In this cohort, the same risk factors (fasting and 2-h glucose, fasting C-peptide, and fasting PI levels) were predictive for the development of NIDDM. We conclude that Japanese-American men who subsequently develop NIDDM have more IAF and increased glucose, C-peptide, and PI levels. These data suggest that alterations in PI may be a new marker for the subsequent development of NTODM.

[1]  W. Sheu,et al.  Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance. , 1993, The Journal of clinical endocrinology and metabolism.

[2]  N. Day,et al.  Raised proinsulin concentration as early indicator of beta cell dysfunction. , 1991, BMJ.

[3]  P. Bennett,et al.  Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus. , 1990, The Journal of clinical endocrinology and metabolism.

[4]  R. Kronmal.  Spurious Correlation and the Fallacy of the Ratio Standard Revisited , 1993 .

[5]  S. O’Rahilly,et al.  Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. , 1988, The New England journal of medicine.

[6]  M. Ballmann,et al.  Preferential release of proinsulin relative to insulin in non-insulin-dependent diabetes mellitus. , 1988, Acta endocrinologica.

[7]  U. Hanson,et al.  Follow-Up of Women With Previous GDM: Insulin, C-Peptide, and Proinsulin Responses to Oral Glucose Load , 1991, Diabetes.

[8]  E. Ravussin,et al.  Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. , 1993, The New England journal of medicine.

[9]  J. Sturis,et al.  Lack of control by glucose of ultradian insulin secretory oscillations in impaired glucose tolerance and in non-insulin-dependent diabetes mellitus. , 1993, The Journal of clinical investigation.

[10]  S. Kahn,et al.  Effect of insulin resistance and hyperglycemia on proinsulin release in a primate model of diabetes mellitus. , 1992, The Journal of clinical endocrinology and metabolism.

[11]  S. Haffner,et al.  Incidence of Type II Diabetes in Mexican Americans Predicted by Fasting Insulin and Glucose Levels, Obesity, and Body-Fat Distribution , 1990, Diabetes.

[12]  R. Bergman,et al.  Quantification of the Relationship Between Insulin Sensitivity and β-Cell Function in Human Subjects: Evidence for a Hyperbolic Function , 1993, Diabetes.

[13]  D. Porte,et al.  A sensitive radioimmunoassay for human proinsulin, with sequential use of antisera to C-peptide and insulin. , 1986, Clinical chemistry.

[14]  P. Bennett,et al.  The natural history of impaired glucose tolerance in the Pima Indians. , 1988, The New England journal of medicine.

[15]  R. Sicree,et al.  Plasma Insulin Response Among Nauruans: Prediction of Deterioration in Glucose Tolerance Over 6 Yr , 1987, Diabetes.

[16]  R. Mueller,et al.  Splanchnic Insulin Dynamics and Secretion Pulsatilities in Abdominal Obesity , 1994, Diabetes.

[17]  A. Krolewski,et al.  Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. , 1990, Annals of internal medicine.

[18]  H. Yki-Järvinen,et al.  The effect of exogenous hyperinsulinemia on proinsulin secretion in normal man, obese subjects, and patients with insulinoma. , 1986, The Journal of clinical endocrinology and metabolism.

[19]  S. Kahn,et al.  Hyperproinsulinemia and Amyloid in NIDDM: Clues to Etiology of Islet β-Cell Dysfunction? , 1989, Diabetes.

[20]  P. Wahl,et al.  Prevalence of Diabetes Mellitus and Impaired Glucose Tolerance Among Second-Generation Japanese-American Men , 1987, Diabetes.

[21]  A. Rubenstein,et al.  Circulating proinsulin in patients with maturity onset diabetes. , 1977, The American journal of medicine.

[22]  P. Wahl,et al.  Association of fasting glucose levels with a delayed secretion of insulin after oral glucose in subjects with glucose intolerance. , 1990, The Journal of clinical endocrinology and metabolism.

[23]  J. A. Scarlett,et al.  Insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitus. , 1982, The American journal of physiology.

[24]  D. Owens,et al.  INSULIN DEFICIENCY IN NON-INSULIN-DEPENDENT DIABETES , 1989, The Lancet.

[25]  P. Bennett,et al.  A two-step model for development of non-insulin-dependent diabetes. , 1991, The American journal of medicine.

[26]  P. Wahl,et al.  Abnormal body fat distribution detected by computed tomography in diabetic men. , 1986, Investigative radiology.

[27]  P. Wahl,et al.  Association of Elevated Fasting C-Peptide Level and Increased Intra-Abdominal Fat Distribution With Development of NIDDM in Japanese-American Men , 1990, Diabetes.

[28]  J. Halter,et al.  Insulin Resistance and Impaired Insulin Secretion in Subjects with Histories of Gestational Diabetes Mellitus , 1985, Diabetes.

[29]  D. Porte,et al.  Islet Function and Insulin Sensitivity in the Non‐diabetic Offspring of Conjugal Type 2 Diabetic Patients , 1990, Diabetic medicine : a journal of the British Diabetic Association.

[30]  P. Wahl,et al.  Prevalence of Complications Among Second-Generation Japanese-American Men With Diabetes, Impaired Glucose Tolerance, or Normal Glucose Tolerance , 1987, Diabetes.

[31]  J. Halter,et al.  Pathophysiology of Insulin Secretion in Non-insulin-dependent Diabetes Mellitus , 1984, Diabetes Care.

[32]  M. Davies,et al.  Insulin Deficiency and Increased Plasma Concentration of Intact and 32/33 Split Proinsulin in Subjects with Impaired Glucose Tolerance , 1993, Diabetic medicine : a journal of the British Diabetic Association.

[33]  J. Halter,et al.  Chronic chlorpropamide therapy of noninsulin-dependent diabetes augments basal and stimulated insulin secretion by increasing islet sensitivity to glucose. , 1982, The Journal of clinical endocrinology and metabolism.

[34]  W. Duckworth,et al.  Direct measurement of plasma proinsulin in normal and diabetic subjects. , 1972, The American journal of medicine.